AAAAAA
Results: 1-25/34
Authors:
Warren, KS
Verschoor, EJ
Langenhuijzen, S",Heriyanto,"Swan, RA
Vigilant, L
Heeney, JL
Citation: Ks. Warren et al., Speciation and intrasubspecific variation of Bornean orangutans, Pongo pygmaeus pygmaeus, MOL BIOL EV, 18(4), 2001, pp. 472-480
Authors:
Mooij, P
Heeney, JL
Citation: P. Mooij et Jl. Heeney, Rational development of prophylactic HIV vaccines based on structural and regulatory proteins, VACCINE, 20(3-4), 2001, pp. 304-321
Authors:
Rosenwirth, B
Kuhn, EM
Heeney, JL
Hurpin, C
Tartaglia, J
Bonnet, MC
Moingeon, P
Erdile, L
Citation: B. Rosenwirth et al., Safety and immunogenicity of ALVAC wild-type human p53 (vCP207) by the intravenous route in rhesus macaques, VACCINE, 19(13-14), 2001, pp. 1661-1670
Authors:
Koopman, G
Dalgleish, AG
Bhogal, BS
Haaksma, AGM
Heeney, JL
Citation: G. Koopman et al., Changes in dendritic cell subsets in the lymph nodes or rhesus macaques after application of glucocorticoids, HUMAN IMMUN, 62(3), 2001, pp. 208-214
Rhesus macaque and chimpanzee DC-SIGN act as HIV/SIV gp120 trans-receptors, similar to human DC-SIGN
Authors:
Geijtenbeek, TBH
Koopman, G
van Duijnhoven, GCF
van Vliet, SJ
van Schijndel, ACHW
Engering, A
Heeney, JL
van Kooyk, Y
Citation: Tbh. Geijtenbeek et al., Rhesus macaque and chimpanzee DC-SIGN act as HIV/SIV gp120 trans-receptors, similar to human DC-SIGN, IMMUNOL LET, 79(1-2), 2001, pp. 101-107
Authors:
Rizzo, P
Matker, C
Powers, A
Setlak, P
Heeney, JL
Ratner, H
Carbone, M
Citation: P. Rizzo et al., No evidence of HIV and SIV sequences in two separate lots of polio vaccines used in the first US polio vaccine campaign, VIROLOGY, 287(1), 2001, pp. 13-17
Authors:
Munch, J
Adam, N
Finze, N
Stolte, N
Stahl-Hennig, C
Fuchs, D
Ten Haaft, P
Heeney, JL
Kirchhoff, F
Citation: J. Munch et al., Simian immunodeficiency virus in which nef and U3 sequences do not overlapreplicates efficiently in vitro and in vivo in rhesus macaques, J VIROLOGY, 75(17), 2001, pp. 8137-8146
Authors:
Balla-Jhagjhoorsingh, SS
Mooij, P
ten Haaft, PJF
Bogers, WMJM
Teeuwsen, VJP
Koopman, G
Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells, J INFEC DIS, 184(2), 2001, pp. 136-143
Authors:
Verschoor, EJ
Warren, KS
Langenhuijzen, S",Heriyanto,"Swan, RA
Heeney, JL
Citation: Ej. Verschoor et al., Analysis of two genomic variants of orang-utan hepadnavirus and their relationship to other primate hepatitis B-like viruses, J GEN VIROL, 82, 2001, pp. 893-897
Authors:
Ensser, A
Glykofrydes, D
Niphuis, H
Kuhn, EM
Rosenwirth, B
Heeney, JL
Niedobitek, G
Muller-Fleckenstein, I
Fleckenstein, B
Citation: A. Ensser et al., Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologue, J EXP MED, 193(5), 2001, pp. 637-642
Authors:
Balla-Jhagjhoorsingh, SS
Mooij, P
ten Haaft, PJF
Bogers, WMJM
Teeuwsen, VJP
Koopman, G
Heeney, JL
Citation: Ss. Balla-jhagjhoorsingh et al., Protection from secondary human immunodeficiency virus type 1 infection inchimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells, AM NATURAL, 158(2), 2001, pp. 136-143
Authors:
Czub, S
Koutsilieri, E
Sopper, S
Czub, M
Stahl-Hennig, C
Muller, JG
Pedersen, V
Gsell, W
Heeney, JL
Gerlach, M
Gosztonyi, G
Riederer, P
ter Meulen, V
Citation: S. Czub et al., Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs, ACT NEUROP, 101(2), 2001, pp. 85-91
Authors:
Heeney, JL
Hahn, BH
Citation: Jl. Heeney et Bh. Hahn, Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development, AIDS, 14, 2000, pp. S125-S127
Authors:
Heeney, JL
Koopman, G
Rosenwirth, B
Bogers, W
van Dijk, J
Nieuwenhuis, I
Niphuis, H
ten Haaft, P
Hanke, T
Rhodes, G
Berglund, P
Burny, A
Bex, F
Sutter, G
Liljestrom, P
Citation: Jl. Heeney et al., A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens, J MED PRIM, 29(3-4), 2000, pp. 268-273
Authors:
Mooij, P
Bogers, WMJM
Oostermeijer, M
Koornstra, W
Ten Haaft, PJF
Verstrepen, BE
Van der Auwera, G
Heeney, JL
Citation: P. Mooij et al., Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy, J VIROLOGY, 74(9), 2000, pp. 4017-4027
Authors:
Rosenwirth, B
ten Haaft, P
Bogers, WMJM
Nieuwenhuis, IG
Niphuis, H
Kuhn, EM
Bischofberger, N
Heeney, JL
Uberla, K
Citation: B. Rosenwirth et al., Antiretroviral therapy during primary immunodeficiency virus infection caninduce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques, J VIROLOGY, 74(4), 2000, pp. 1704-1711
Authors:
Glykofrydes, D
Niphuis, H
Kuhn, EM
Rosenwirth, B
Heeney, JL
Bruder, J
Niedobitek, G
Muller-Fleckenstein, I
Fleckenstein, B
Ensser, A
Citation: D. Glykofrydes et al., Herpesvirus Saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity, J VIROLOGY, 74(24), 2000, pp. 11919-11927
Authors:
Beaumont, T
Broersen, S
van Nuenen, AD
Huisman, HG
Husman, AMD
Heeney, JL
Schuitemaker, H
Citation: T. Beaumont et al., Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees, J VIROLOGY, 74(17), 2000, pp. 7699-7707
Authors:
Mori, K
Yasutomi, Y
Sawada, S
Villinger, F
Sugama, K
Rosenwith, B
Heeney, JL
Uberla, K
Yamazaki, S
Ansari, AA
Rubsamen-Waigmann, H
Citation: K. Mori et al., Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection, J VIROLOGY, 74(13), 2000, pp. 5747-5753
Authors:
Holterman, L
Niphuis, H
Koornstra, W
Dubbes, R
ten Haaft, P
Heeney, JL
Citation: L. Holterman et al., The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques, J GEN VIROL, 81, 2000, pp. 1719-1726
Authors:
Ohnimus, H
Heinkelein, M
Heeney, JL
Walker, CM
Jassoy, C
Citation: H. Ohnimus et al., Lysis of HIV envelope glycoprotein-expressing cells by CD4+ T lymphocytes from chimpanzees, J ACQ IMM D, 20(2), 1999, pp. 207-208
Authors:
Koopman, G
Haaksma, AGM
ten Velden, J
Hack, CE
Heeney, JL
Citation: G. Koopman et al., The relative resistance of HIV type 1-infected chimpanzees to AIDS correlates with the maintenance of follicular architecture and the absence of infiltration by CD8(+) cytotoxic T lymphocytes, AIDS RES H, 15(4), 1999, pp. 365-373
Authors:
Heeney, JL
Beverley, P
McMichael, A
Shearer, G
Strominger, J
Wahren, B
Weber, J
Gotch, F
Citation: Jl. Heeney et al., Immune correlates of protection from HIV and AIDS - more answers but yet more questions, IMMUNOL TOD, 20(6), 1999, pp. 247-251
Authors:
Rosenwirth, B
Bogers, WMJM
Nieuwenhuis, IG
Ten Haaft, P
Niphuis, H
Kuhn, EM
Bischofberger, N
Erfle, V
Sutter, G
Berglund, P
Liljestrom, P
Uberla, K
Heeney, JL
Citation: B. Rosenwirth et al., An anti-HIV strategy combining chemotherapy and therapeutic vaccination, J MED PRIM, 28(4-5), 1999, pp. 195-205
Authors:
Verschoor, EJ
Davis, D
van Gils, M
Koopman, G
Mooij, P
Oostermeijer, H
Ten Haaft, P
Verstrepen, B
Rosenwirth, B
Morein, B
Barnett, SW
Heeney, JL
Citation: Ej. Verschoor et al., Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus, J MED PRIM, 28(4-5), 1999, pp. 224-232